Search For "mylan"
Viatris Certified as a Great Place to Work in India for the Fourth Consecu
Updated : 11 months, 2 weeks ago IST
Bangalore (Karnataka) [India], April 2: Mylan Laboratories Limited (a Viatris Company) has been recognized with the Great Place to Work® Certification™ in India for the fourth consecutive year. This recognition highlights Viatris' unwavering commitment to fostering a culture of in
Read More
Viatris Certified as a Great Place to Work in India for the Third Consecut
Updated : 2 years ago IST
Telangana (Hyderabad) [India], February 19: Mylan Laboratories Limited (a Viatris Company) has been recognized with the prestigious Great Place to Work® CertificationTM in India for the third consecutive time. This recognition is a testament to Viatris' commitment to fostering a posit
Read More
Sri Aurobindo Institute of Pharmacy organized the 2nd Pharma HR summit on
Updated : 3 years, 11 months ago IST
New Delhi [India], March 22 (ANI/SRV): To provide holistic development of students and to match Industry expectations of the pharma sector, Sri Aurobindo Institute of Pharmacy organized the 2nd HR Summit on the theme -- 'Scientific Excellence to Employability: A Pharma HR Perspective' on 12
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Black Fungus: Chandigarh orders 2,000 vials of Amphotericin B
Updated : 4 years, 9 months ago IST
Chandigarh (Haryana) [India], May 25 (ANI): Advisor of Chandigarh Administration, Manoj Parida on Monday informed that Union Territory has placed an order for 2,000 vials of Liposomal Amphotericin B injection, a drug which is used in treatment of black fungus.
Read More
Nitin Gadkari directs Nagpur DC to distribute Remdesivir injections to oth
Updated : 4 years, 11 months ago IST
New Delhi [India], April 12 (ANI): Union Minister Nitin Gadkari on Monday directed Nagpur District Collector Ravindra Thackeray to distribute Remdesivir injections received through Mylan India and Sun Pharma to other districts of Vidarbha in Maharashtra.
Read More
New insulin glargine injection launched in US for diabetes patients
Updated : 5 years, 6 months ago IST
Bengaluru (Karnataka) [India], Aug 31 (ANI): Biocon Biologics and Mylan on Monday announced the US launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and paediatric patients with type 1 diabetes a
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Mylan announces commercial launch of its Remdesivir under brand name DESRE
Updated : 5 years, 7 months ago IST
New Delhi/Bengaluru [India], July 20 (ANI): Pharmaceutical company Mylan on Monday announced the commercial launch of its Remdesivir under the brand name DESREM™ in India to address urgent, unmet needs amid COVID-19 pandemic.
Read More
DCGI instructs pharma giants manufacturing remdesivir to upload details of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted eme
Updated : 5 years, 8 months ago IST
New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on Thursday.
Read More